Efficacy and safety of intranasal esketamine for the rapid reduction of symptoms of depression and suicidality in patients at imminent risk for suicide: Results of a double-blind, randomized, placebo-controlled study - Canuso, C M; Singh, J B; Fedgchin, M (Am J Psychiatry, 2018)
et al.